This ticker has not been starred yet PBYI Puma Biotechnology, Inc.
Pharmaceutical Preparations
Book value per $ invested $ 0.48
Leverage 43.18%
Market Cap $ 238.6m
PE 6.47
Dividend Yield 0.00%
Profit $ 36.9m
Margin 17.34%

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to improve cancer care in the United States and internationally. The company is headquartered in Los Angeles, California.

Subscribe Now For Access - Only $1.99 Per Month